A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The government is working to head off human bird flu infections. The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest rate outlook.

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company’s bird flu vaccine, as fears of a new ...